Table 11. Total consumption (DDD/1,000 inhabitant-days) of oral sulfamethoxazole-trimethoprim (J01EE01), ciprofloxacin (J01MA02) and nitrofurantoin (J01XE01), generally prescribed for treatment of urinary tract infections, dispensed by retail pharmacies in Canadian provinces, 2000-2009.
ATC Class Antimicrobial Province DDD/1,000 inhabitant-days
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
The numbers presented in this table represent all respective antimicrobial treatments, not those dispensed solely for the treatment of urinary tract infections.
ATC = Anatomical Therapeutic Chemical. DDD = Defined daily dose. NA = Not available
Prior to 2005 data for the provinces of Prince Edward Island and Newfoundland and Labrador were provided in a combined format. As of 2005, data is available at the individual provincial level.
Combinations of sulfonamides and trimethoprim, including derivatives (J01EE) Sulfamethoxazole trimethoprim (J01EE01) British Columbia 1.61 1.47 1.31 1.23 1.06 0.97 0.97 0.96 0.95 0.91
Alberta 1.68 1.44 1.30 1.29 1.15 1.11 1.08 0.98 0.98 0.96
Saskatchewan 2.23 1.91 1.74 1.63 1.37 1.41 1.52 1.44 1.38 1.41
Manitoba 1.65 1.60 1.56 1.64 1.45 1.06 1.14 1.07 1.05 1.05
Ontario 1.21 1.16 1.07 0.97 0.86 0.82 0.82 0.75 0.73 0.73
Québec 0.96 0.82 0.67 0.59 0.50 0.42 0.41 0.39 0.39 0.38
New Brunswick 2.20 1.78 1.64 1.45 1.26 1.13 1.16 1.09 1.05 1.03
Nova Scotia 1.76 1.52 1.34 1.27 1.23 1.19 1.21 1.16 1.16 1.17
Prince Edward Island and Newfoundland and Labrador 3.11 2.70 2.26 2.37 2.15 NA NA NA NA NA
Prince Edward Island NA NA NA NA NA 1.61 1.52 1.45 1.29 1.34
Newfoundland and Labrador NA NA NA NA NA 1.88 1.77 1.69 1.66 1.71
Fluoroquinolones (J01MA) Ciprofloxacin (J01MA02) British Columbia 1.08 1.16 1.19 1.23 1.23 1.25 1.31 1.31 1.29 1.23
Alberta 0.98 1.00 1.03 1.14 1.21 1.26 1.23 1.25 1.27 1.25
Saskatchewan 0.69 0.77 0.80 0.72 0.68 0.78 0.88 0.98 0.94 1.01
Manitoba 0.80 0.88 0.94 1.15 1.25 1.08 1.20 1.26 1.23 1.27
Ontario 1.38 1.05 0.98 0.97 0.98 1.05 1.19 1.16 1.15 1.13
Québec 0.96 1.04 1.03 1.07 1.05 1.01 1.09 1.11 1.12 1.16
New Brunswick 1.19 1.39 0.84 0.75 0.77 0.77 0.88 0.91 0.97 0.99
Nova Scotia 0.71 0.80 0.89 0.98 1.02 1.03 1.09 1.09 1.13 1.18
Prince Edward Island and Newfoundland and Labrador 1.79 2.06 2.35 2.37 2.45 NA NA NA NA NA
Prince Edward Island NA NA NA NA NA 0.85 0.91 1.05 1.14 1.14
Newfoundland and Labrador NA NA NA NA NA 3.24 3.45 3.51 3.52 3.49
Nitrofuran derivatives (J01XE) Nitrofurantoin (J01XE01) British Columbia 0.40 0.39 0.40 0.44 0.49 0.51 0.56 0.58 0.63 0.68
Alberta 0.41 0.42 0.42 0.44 0.48 0.50 0.56 0.55 0.59 0.61
Saskatchewan 0.91 0.95 0.87 0.87 0.88 0.90 0.97 0.98 0.99 1.04
Manitoba 0.35 0.37 0.36 0.43 0.46 0.34 0.39 0.41 0.44 0.47
Ontario 0.48 0.52 0.55 0.57 0.59 0.66 0.73 0.72 0.77 0.83
Québec 0.22 0.24 0.24 0.25 0.26 0.25 0.27 0.28 0.29 0.32
New Brunswick 0.47 0.47 0.55 0.58 0.61 0.59 0.68 0.69 0.73 0.74
Nova Scotia 0.74 0.70 0.67 0.68 0.69 0.76 0.89 0.92 0.95 0.97
Prince Edward Island and Newfoundland and Labrador 0.42 0.38 0.38 0.39 0.39 NA NA NA NA NA
Prince Edward Island NA NA NA NA NA 0.44 0.53 0.64 0.74 0.75
Newfoundland and Labrador NA NA NA NA NA 0.38 0.45 0.52 0.59 0.60

Return to the previous link